Mechanistic Evaluation of Guanfacine on Drinking Behavior
Mental Health & Behavioral Research
What is the purpose of this trial?
In this study, we are seeking individuals who are interested in reducing or cutting back their drinking behavior. We will be looking at how the medication Intuniv, which is Guanfacine, influences drinking behavior. Guanfacine is a medication that has been approved by the Food and Drug Administration (FDA) to treat high blood pressure and ADHD. There are three phases to the study.
- Ages21 - 70 years
- Trial withNational Institutes of Health (NIH)
- Start Date02/28/2019
- End Date09/28/2020
- Last Updated07/04/2019
- Study HIC#2000023970